KWALITY PHARMACEUTICALS
|
KWALITY PHARMACEUTICALS Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 18.67 | 115.64 | 14.60 | 8.02 | 7.28 |
CEPS(Rs) | 33.00 | 125.89 | 20.61 | 12.18 | 10.29 |
DPS(Rs) | - | - | - | - | - |
Book NAV/Share(Rs) | 192.48 | 173.81 | 58.16 | 43.57 | 35.14 |
Tax Rate(%) | 24.61 | 25.77 | 30.01 | 24.83 | 30.74 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 24.19 | 37.63 | 11.01 | 10.21 | 9.45 |
EBIT Margin(%) | 12.82 | 36.06 | 9.14 | 9.65 | 7.94 |
Pre Tax Margin(%) | 10.19 | 35.42 | 8.12 | 7.84 | 6.56 |
PAT Margin (%) | 7.68 | 26.29 | 5.68 | 5.89 | 4.54 |
Cash Profit Margin (%) | 13.64 | 28.64 | 8.16 | 9.07 | 6.42 |
Performance Ratios | |||||
ROA(%) | 5.55 | 47.33 | 9.97 | 6.90 | 7.50 |
ROE(%) | 10.15 | 99.66 | 28.21 | 20.10 | 23.13 |
ROCE(%) | 12.06 | 95.32 | 26.36 | 18.49 | 21.91 |
Asset Turnover(x) | 0.72 | 1.80 | 1.75 | 1.17 | 1.65 |
Sales/Fixed Asset(x) | 1.68 | 4.34 | 3.62 | 2.53 | 3.98 |
Working Capital/Sales(x) | 3.09 | 5.16 | 9.49 | 6.55 | 11.45 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.59 | 0.23 | 0.28 | 0.40 | 0.25 |
Receivable days | 102.38 | 41.94 | 46.00 | 90.08 | 82.82 |
Inventory Days | 101.54 | 28.29 | 27.71 | 44.10 | 28.84 |
Payable days | 183.20 | 78.14 | 54.20 | 83.90 | 59.90 |
Valuation Parameters | |||||
PER(x) | 16.47 | 5.02 | 3.84 | 3.19 | 5.09 |
PCE(x) | 9.32 | 4.61 | 2.72 | 2.10 | 3.60 |
Price/Book(x) | 1.60 | 3.34 | 0.96 | 0.59 | 1.05 |
Yield(%) | - | - | - | - | - |
EV/Net Sales(x) | 1.60 | 1.43 | 0.36 | 0.43 | 0.40 |
EV/Core EBITDA(x) | 6.31 | 3.72 | 3.07 | 3.35 | 4.03 |
EV/EBIT(x) | 12.49 | 3.96 | 3.90 | 4.46 | 4.98 |
EV/CE(x) | 1.14 | 1.91 | 0.56 | 0.45 | 0.62 |
M Cap / Sales | 1.27 | 1.32 | 0.22 | 0.19 | 0.23 |
Growth Ratio | |||||
Net Sales Growth(%) | -44.97 | 74.11 | 88.10 | -16.23 | 20.95 |
Core EBITDA Growth(%) | -63.65 | 475.33 | 70.33 | 9.52 | 30.76 |
EBIT Growth(%) | -80.44 | 586.65 | 78.21 | 1.81 | 38.94 |
PAT Growth(%) | -83.93 | 705.63 | 81.40 | 8.60 | 70.91 |
EPS Growth(%) | -83.86 | 692.23 | 82.11 | 10.13 | 66.12 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.45 | 0.35 | 0.68 | 0.77 | 0.79 |
Current Ratio(x) | 1.65 | 1.63 | 1.35 | 1.31 | 1.24 |
Quick Ratio(x) | 0.96 | 1.25 | 1.14 | 1.00 | 1.06 |
Interest Cover(x) | 4.87 | 56.38 | 8.93 | 5.32 | 5.76 |
Total Debt/Mcap(x) | 0.28 | 0.11 | 0.71 | 1.32 | 0.75 |
Compare Financial Ratios of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹528.7 Cr | 0.7% | 12.7% | 59.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹368,598.0 Cr | 2% | -0.3% | 59.8% | Stock Analytics | |
CIPLA | ₹114,654.0 Cr | 6% | 2.8% | 50.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,348.0 Cr | 3.7% | 5.8% | 17.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,499.0 Cr | 2.6% | 7.9% | 94.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,429.4 Cr | -1.3% | -2.8% | 31.5% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | 0.7% |
12.7% |
59.4% |
SENSEX | 1.7% |
-0.8% |
19% |
You may also like the below Video Courses